Loading color scheme

The Black Box of Drug Pricing has Been Opened; PBM MC-Rx Urges Accountability

Several states have passed drug price transparency laws that require drug makers to report the reasons behind dramatic price increases. More states will follow. These laws represent an important first step in shining a light on why drug prices are rapidly rising. MC-Rx, a PBM advocating for change, argues the need not just for transparency, but accountability in the often secretive flow of funds from the pharmaceutical manufacturer to the ultimate consumer.

Read more
MC-Rx Urges Industry Accountability for PBMs with JoTo PR

Drug prices are a heated topic in American society and in the Federal government. Pharmacy Benefit Managers (PBMs) usually take the blame for rising drug costs with rebate practices. MC-Rx, a full-service PBM, is urging others in the industry to be held accountable for their rebate practices.

Read more